Member Info for Bantham

Ok thanks EC.

So that says - full approval in the US for Breast cancer. No restrictions. Good.

And it says use for all other cancers restricted to drug trials.

Is that correct?

Isn’t that what TG2D has been saying or am i missing something?

Thanks EC. Could you give us a time during the presentation that he gives a precise answer to the question some of us are struggling with please?

TG2D - now you mention it i remember that. Word soup. Absolutely he was vague. I wonder why.

Miavoce - the question is what specific statements can you source direct from Angle that supports your view? I think you might struggle.

I absolutely don’t know the answer to this question of what precisely Parsortix can be used for ATM - but given the history of this company that certainly raises a question or two.

Hi Miavoce

Commercially - i agree. Shareholders do not need to understand in order for Newland to close some deals.

But it’s a point of basic communication. Why not make it totally clear to your shareholders? I mean if it is as you think, allowing this confusion is just id1otic when you would think you need a strong share price for an equity issue in due course.

And the fact that Newland hasn’t closed any significant deals ( yes i do know about the $250k Eisai ) raises questions doesn’t it ?

The fact that this confusion exits is symptomatic of the failures of communication of this company.

It should be crystal clear from Angle’s communications exactly what can and cannot be done today and what that means commercially. It should be very simple to spell this out.

I admit to being confused on this point.

It’s very basic and very important.

Honestly - why do I you get excited about this.

It’s just ramping and selling out.

We’ve all seen it here many, many times.

Spike. Drop. End of story.

How exciting - the price is going up for no reason.

Here come the rampers.

I wonder how long this little spike will last :)

The sp does indeed say it all.

Three months ago it hit 37p on hype and hot air. And now it’s at 12.25p.

Thanks. So he’s reposted something from months ago. How ridiculous.

What is this? There are no results today.

I agree TG2D.

I have seen lists of so-called target markets but few seem to last long enough to be reported on. But I have seen no commercial or strategic plan.

IMO - the plan can be summarised as ‘ somewhere over the rainbow skies are blue’.

Jackbal - agreed on all.

IMO most Board’s would have fired him now for serially raising expectations allied with zero delivery. And he’s burned through £100m if i remember correctly.

But my guess is there is no obvious replacement so this pack of cards stands or falls with him. So i think i know how this might end…..

BTW i didn’t do the asterisks. You can’t even use a word for drinks anymore without automatic censorship!!

jackbal - agreed on that and on the 10p comments others have made.

but i assume that could be handled with an egm maybe??

but i still think the problem isn’t just technical - where smart lawyers and brokers identify technical solutions.

like fevertreeman i think the problem is newland has no commercial traction, has consistently failed to live up to expectations and has zero credibility so no institution will support any of his future fantasies with their cash.

i also suggest that tg2d and ec get together for ****tails - they might find it’s the start of a beautiful relationship. and then we can make a feature film about an improbable romance. that might be the best way of making some money out of this.

ADw i can see why you would hope for a Placing. The dilution would be massive, but at least Angle could have a 2 year plus cash runway if it raised £10m or £15m ( i am guessing ).

The bigger risk is that Newland has no institutional support and no commercial progress to show on his £6.6m sales forecast. And a possible consequence of that is that there is no source of institutional funds - IE potentially no-one wants to support him at any price. And remember they would need £10m to £15m to de-risk the balance sheet. In other words - raising £5m just won’t be an option. So it’s significant cash required. If this risk crystallised it wouldn’t result in a very happy ending .

What info do you have which suggests this is cheap?

Feels like an equity issue or some other bad news coming along.

I had thought with Rudd on the Board they would at least have their Governance in order. Maybe that was rash.

Agree with all you say Adw.

IMHO - they are just nowhere near commercialisation and this could turn out to be a house of cards by year end because without proper revenues there can be no funding. But maybe the rabbit will finally get pulled out of the hat.

The TG2D / EC jousting is endless. If they met they would probably fall in love :)

Here we go. Rampers ramping on a zero content RNS. Just another day at Angle.

‘ We look forward to discussions with translational researchers and industry representatives at this conference to explore opportunities for sales, collaboration, and partnerships.’

How about an order which gets some revenues towards the £6.6m promise?